v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income $ 2,111 $ 1,974
Adjustments to reconcile net income to net cash flows from operating activities:    
Gains on marketable securities, net (15) (119)
Depreciation and amortization 2,275 2,255
Allowance for equity funds (174) (147)
Equity (income) loss, net of distributions 332 332
Net power cost deferrals (73) (61)
Amortization of net power cost deferrals 458 430
Other changes in regulatory assets and liabilities 118 (162)
Deferred income taxes and investment tax credits, net 323 (107)
Other, net 21 158
Changes in other operating assets and liabilities, net of effects from acquisitions:    
Trade receivables and other assets (509) (405)
Derivative collateral, net (15) 14
Pension and other postretirement benefit plans (6) (6)
Accrued property, income and other taxes, net 293 107
Accounts payable and other liabilities 123 114
Wildfires insurance receivable 0 98
Wildfires liability (589) (155)
Net cash flows from operating activities 4,673 4,320
Cash flows from investing activities:    
Capital expenditures (4,949) (4,573)
Purchases of marketable securities (280) (238)
Proceeds from sales of marketable securities 351 811
Purchases of U.S. Treasury Bills (289) (39)
Proceeds from maturities of U.S. Treasury Bills 43 0
Equity method investments (20) (45)
Other, net 35 13
Net cash flows from investing activities (5,109) (4,071)
Cash flows from financing activities:    
Preferred stock redemptions 0 (481)
Preferred dividends 0 (3)
Repayments of BHE senior debt 0 (1,650)
Proceeds from subsidiary debt 4,564 2,670
Repayments of subsidiary debt (1,253) (388)
Net (repayments of) proceeds from short-term debt (609) 551
Distributions to noncontrolling interests (115) (96)
Other, net 219 (31)
Net cash flows from financing activities 2,806 572
Effect of exchange rate changes (10) 13
Net change in cash and cash equivalents and restricted cash and cash equivalents 2,360 834
Cash and cash equivalents and restricted cash and cash equivalents at beginning of period 1,878 1,586
Cash and cash equivalents and restricted cash and cash equivalents at end of period $ 4,238 $ 2,420